Kai Strothmann

Background

About Kai Strothmann

Kai is a highly versatile & well-versed leader in the healthcare industry with 20 years of international experience in strategic business functions with a strong track record in the building & optimization of pipeline & commercial stage drug or medical device product portfolios across diverse therapeutic areas. Coming from a scientific background (Pharmacist, PhD in Pharmacology), Kai has 20 years of expertise in Portfolio & Project Management, Business Development/M&A, Strategic Marketing, Global Brand Management, Market Access and Commercialization of prescription drugs & medical devices, gained in leading large cross-functional teams at a) stock-market listed big pharma, b) a world leading asset manager in the financial industry, c) a global market leader in medical devices & services and d) a privately held midsize international specialty pharma company. Key areas of expertise- Leadership of large cross-functional teams in matrix organizations building a strong collaborative working environment - Portfolio Management of pharma/biotech funds, building start-up commercial pharma & MedTech product portfolios, growing and optimizing pipeline/commercial product portfolios in various therapeutic areas with a highly analytical & structured approach - Business Development from in-/out-licensing of development products incl. orphan innovative assets over partnering of commercial stage products to complex acquisitions of mature global prescription brands - Due Diligence of in-licensing & acquisition candidates with responsibility for global commercial due diligence covering forecasting, marketing & sales, medical affairs, market access and pricing & reimbursement - Project Management of in-licensed assets from re-formulation over registration to contract manufacturing & commercial supply - Strategic Marketing in all stages of product lifecycle from pre-clinical drug candidates over clinical stage & global brand launches (incl. formulation technologies) to LCM of mature global brands Languages: English, French, German Additional Expertise: Pharmaceuticals, Biotech, Prescription Drugs, Generics, Orphan Drugs, Drug Development, Medical Devices, R&D Pipeline, Global Brand Plans, KOL Management, Pre-Launch Activities, Market Access, Pricing & Reimbursement, Value Dossier, Launch Readiness, Product Launch, Supply Chain, Strategic Planning, Business Plan, Portfolio Development, Forecasting, NPV, In-licensing, Term Sheet Negotiation, Contract Negotiation, Mergers & Acquisitions, Partnering, Entrepreneurship, Cross-Functional Team Management